Hemophagocytic lymphohistiocytosis secondary to epstein-barr virus reactivation in a patient with COVID-19
<p>Hemophagocytic lymphohistiocytosis (HLH) in coronavirus disease 2019 (COVID-19) is a recognized complication of severe illness. However, this phenomenon has been reported most often in the setting of acute infection. Here we present a case of a patient with a history of severe acute respira...
Saved in:
Main Authors: | Nurfiza Ladak (Author), Kenneth Csehak (Author), Justin Chan (Author), Farnoush Moen (Author) |
---|---|
Format: | Book |
Published: |
Archives of Hematology Case Reports and Reviews - Peertechz Publications,
2022-02-16.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Chronic active Epstein-Barr virus-associated secondary hemophagocytic lymphohistiocytosis in pregnancy: a case report
by: Masaya Takahashi, et al.
Published: (2021) -
Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis: response to HLH-04 treatment protocol
by: Elva Jiménez-Hernández, et al.
Published: (2016) -
Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis Resembling Recurrent Follicular Lymphoma: A Case Report
by: Chan Hee Park, et al.
Published: (2022) -
Case of Chronic Active Epstein-Barr Virus Infection Developed Hemophagocytic Lymphohistiocytosis after COVID-19 Infection
by: Sumin Jo, et al.
Published: (2023) -
Clinical utility of plasma Epstein-Barr virus DNA monitoring in pediatric Epstein‐Barr virus-associated hemophagocytic lymphohistiocytosis: a Chinese retrospective observational study
by: Wenzhi Zhang, et al.
Published: (2024)